# POMALYST
> **NDA204026** · New Drug Application · Sponsor: BRISTOL · Approved 2013-02-08
## Drug
- **FDA Application Number:** NDA204026
- **Application type:** New Drug Application
- **Brand name:** POMALYST
- **Generic name:** POMALIDOMIDE
- **Active ingredients:** POMALIDOMIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BRISTOL
- **Manufacturer:** Celgene Corporation
- **First approval:** 2013-02-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204026)
---
*AI Analytics · CC0 1.0*